Adherence to HIV treatment regimens: systematic literature review and meta-analysis

References

• Panel on Antiretroviral Guidelines for Adults and Adolescents: guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescentsDepartment of Health and Human Services [updated July 14, 2016]. Available from: http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdfAccessed March 23, 2017
   Google Scholar
• AstutiNMaggioloFSingle-tablet regimens in HIV therapyInfect Dis Ther2014311725134808
   PubMedGoogle Scholar
• DejesusEYoungBMorales-RamirezJOSimplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine, and tenofovir disoproxil fumarate versus unmodified anti-retroviral therapy in virologically suppressed HIV-1-infected patientsJ Acquir Immune Defic Syndr20095116317419357529
   PubMed Web of Science ®Google Scholar
• GlassTRDe GeestSHirschelBSelf-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patientsAntivir Ther2008137785
   PubMed Web of Science ®Google Scholar
• HannaDBHessolNAGolubETIncrease in single-tablet regimen use and associated improvements in adherence-related outcomes in HIV-infected womenJ Acquir Immune Defic Syndr20146558759624326606
   PubMed Web of Science ®Google Scholar
• ParientiJJBangsbergDRVerdonRGardnerEMBetter adherence with once-daily antiretroviral regimens: a meta-analysisClin Infect Dis20094848448819140758
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO)Adherence to long-term therapiesEvidence for action12003 Available from: http://apps.who.int/iris/bitstream/10665/42682/1/9241545992.pdfAccessed October 31, 2016
   Google Scholar
• WilsonDPLawMGGrulichAECooperDAKaldorJMRelation between HIV viral load and infectiousness: a model-based analysisLancet200837231432018657710
   PubMed Web of Science ®Google Scholar
• HoggRSYipBChanKO’ShaughnessyMMontanerJNonadherence to triple-combination ART is predictive of AIDS progression and death in HIV+ men and womenPresented at the XIII International AIDS ConferenceJuly 9–14; 2000Durban, South Africa Abstract TuOrB419
   Google Scholar
• KitahataMMReedSDDillinghamPWPharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and deathInt J STD AIDS20041580381015601486
   PubMed Web of Science ®Google Scholar
• YehiaBRMehtaJMCiuffetelliDAntiretroviral medication errors remain high but are quickly corrected among hospitalized HIV-infected adultsClin Infect Dis20125559359922610923
   PubMed Web of Science ®Google Scholar
• MannheimerSBMattsJTelzakEQuality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherenceAIDS Care200517102215832830
   PubMed Web of Science ®Google Scholar
• Panel on treatment of HIV-infected pregnant women and prevention of perinatal transmissionRecommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States [updated October 26, 2016] Available from: http://aidsinfo.nih.gov/contentfiles/PerinatalGL.pdfAccessed April 30, 2012
   Google Scholar
• GardnerEMMaraviMERietmeijerCDavidsonAJBurmanWJThe association of adherence to antiretroviral therapy with healthcare utilization and costs for medical careAppl Health Econ Health Policy2008614515519231907
   PubMedGoogle Scholar
• LeisegangRClearySHislopMEarly and late direct costs in a Southern African antiretroviral treatment programme: a retrospective cohort analysisPLoS Med20096e100018919956658
   PubMed Web of Science ®Google Scholar
• GuptaAKArshadSPoulterNRCompliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysisHypertension20105539940720026768
   PubMed Web of Science ®Google Scholar
• O’ConnorJLGardnerEMMannheimerSBFactors associated with adherence amongst 5295 people receiving antiretroviral therapy as part of an international trialJ Infect Dis2013208404923204161
   PubMed Web of Science ®Google Scholar
• SweetDKZhongYZhuoDSignorovitchJReal-world adherence among patients receiving single versus multiple tablet regimens for HIV-1 infection, and associations between adherence and viral suppression: a systematic literature review and meta-analysisPresented at the 20th International AIDS ConferenceJuly 20–25; 2014Melbourne, Australia Abstract MOPE054
   Google Scholar
• UthmanOAParientiDWDowdyDWRegimen simplification in HIV infection toward once-daily dosing and fixed-dose combinations: a meta-analysis and sequential analysis of randomized controlled trialsPoster presented at the XIX International AIDS ConferenceJuly 22–27; 2012Washington, DC, USA Poster TUPE096
   Google Scholar
• PatersonDLSwindellsSMohrJAdherence to protease inhibitor therapy and outcomes in patients with HIV infectionAnn Intern Med2000133213010877736
   PubMed Web of Science ®Google Scholar
• ClayPGNagSGrahamCMNarayananSMeta-analysis of studies comparing single and multi-tablet fixed dose combination HIV treatment regimensMedicine (Baltimore)201594e167726496277
   PubMed Web of Science ®Google Scholar
• BezabheWMChalmersLBereznickiLRPetersonGMAdherence to antiretroviral therapy and virologic failure: a meta-analysisMedicine (Baltimore)201695e336127082595
   PubMed Web of Science ®Google Scholar
• Del CarmenTFreemanRSieglerELSinghHA qualitative analysis of inpatient geriatric consults in the aging HIV populationInnovation in Aging20171Suppl 1835
   Google Scholar
• Martin-IguacelRLlibreJMFriis-MollerNRisk of cardiovascular disease in an aging HIV population: where are we now?Curr HIV/ AIDS Rep20151237538726423407
   PubMed Web of Science ®Google Scholar
• NachegaJBHsuAJUthmanOASpinewineAPhamPAAntiret-roviral therapy adherence and drug-drug interactions in the aging HIV populationAIDS201226Suppl 1S39S5322781176
   PubMedGoogle Scholar
• CherrySBBennerJSHusseinMATangSSNicholMBThe clinical and economic burden of nonadherence with antihypertensive and lipid-lowering therapy in hypertensive patientsValue Health20091248949718783393
   PubMed Web of Science ®Google Scholar
• van OnzenoortHAMengerFENeefCVerberkWJKroonAAde LeeuwPWvan der KuyPHParticipation in a clinical trial enhances adherence and persistence to treatment: a retrospective cohort studyHypertension20115857357821825228
   PubMed Web of Science ®Google Scholar
• MoherDLiberatiATetzlaffJAltmanDGPRISMA GroupPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statementBMJ2009339b253519622551
   PubMed Web of Science ®Google Scholar
• DerSimonianRLairdNMeta-analysis in clinical trialsControl Clin Trials198671771883802833
   PubMed Web of Science ®Google Scholar
• HigginsJPThompsonSGDeeksJJAltmanDGMeasuring inconsistency in meta-analysesBMJ200332755756012958120
   PubMed Web of Science ®Google Scholar
• EggerMDavey SmithGSchneiderMMinderCBias in meta-analysis detected by a simple, graphical testBMJ19973156296349310563
   PubMed Web of Science ®Google Scholar
• TennantSJHesterEKCaulderCRLuZKBookstaverPBAdherence among rural HIV-infected patients in the deep south: a comparison between single-tablet and multi-tablet once-daily regimensJ Int Assoc Provid AIDS Care201514647125331217
   PubMedGoogle Scholar
• CohenCJMeyersJLDavisKLAssociation between daily antiret-roviral pill burden and treatment adherence, hospitalisation risk, and other healthcare utilisation and costs in a US medicaid population with HIVBMJ Open20133e003028
   PubMed Web of Science ®Google Scholar
• CookeCELeeHYXingSAdherence to antiretroviral therapy in managed care members in the United States: a retrospective claims analysisJ Manag Care Pharm201420869224372462
   PubMed Web of Science ®Google Scholar
• KaufTLDavisKLEarnshawSRDavisEASpillover adherence effects of fixed-dose combination HIV therapyPatient Prefer Adherence2012615516422399848
   PubMed Web of Science ®Google Scholar
• LangnessJCookPFGillJBoggsRNetsanetNComparison of adherence rates for antiretroviral, blood pressure, or mental health medications for HIV-positive patients at an academic medical center outpatient pharmacyJ Manag Care Spec Pharm20142080981425062074
   PubMed Web of Science ®Google Scholar
• RogatoFMartinezCRodriguez SagradoMAAdherence in HIV-positive patients treated with single tablet regimens versus recommended once daily multi-pill regimen in clinical practice: findings from the international iSTRAP studyPresented at the 21st International AIDS ConferenceJuly 18–22; 2016Durban, South Africa Abstract THPEB072
   Google Scholar
• RaffiFYazdanpanahYFagnaniFLaurendeauCLafumaAGourmelenJPersistence and adherence to single-tablet regimens in HIV treatment: a cohort study from the French National Healthcare Insurance DatabaseJ Antimicrob Chemother2015702121212825904729
   PubMed Web of Science ®Google Scholar
• SaxPEMeyersJLMugaveroMDavisKLAdherence to antiret-roviral treatment and correlation with risk of hospitalization among commercially insured HIV patients in the United StatesPLoS One20127e3159122384040
   PubMed Web of Science ®Google Scholar
• SuttonSSHardinJWBramleyTJD’SouzaAOBennettCLSingle-versus multiple-tablet HIV regimens: adherence and hospitalization risksAm J Manag Care20162224224827143289
   PubMed Web of Science ®Google Scholar
• TanejaCJudayTGertzogLAdherence and persistence with non-nucleoside reverse transcriptase inhibitor-based antiretroviral regimensExpert Opin Pharmacother2012132111211822970926
   PubMed Web of Science ®Google Scholar
• CohenCJMolinaJMCassettiIWeek 96 efficacy and safety of rilpivirine in treatment-naive, HIV-1 patients in two Phase III random-ized trialsAIDS20132793995023211772
   PubMed Web of Science ®Google Scholar
• JosephsonFAnderssonMCFlamholcLThe relation between treatment outcome and efavirenz, atazanavir or lopinavir exposure in the NORTHIV trial of treatment-naive HIV-1 infected patientsEur J Clin Pharmacol20106634935719967342
   PubMed Web of Science ®Google Scholar
• LathouwersEDe MeyerSDierynckIVirological characterization of patients failing darunavir/ritonavir or lopinavir/ritonavir treatment in the ARTEMIS study: 96-week analysisAntivir Ther2011169910821311113
   PubMed Web of Science ®Google Scholar
• NelsonMGirardPMDemasiRSuboptimal adherence to daruna-vir/ritonavir has minimal effect on efficacy compared with lopinavir/ ritonavir in treatment-naive, HIV-infected patients: 96 week ARTEMIS dataJ Antimicrob Chemother2010651505150920498120
   PubMed Web of Science ®Google Scholar
• SaxPEDeJesusEMillsACo-formulated elvitegravir, cobi-cistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeksLancet20123792439244822748591
   PubMed Web of Science ®Google Scholar
• BaxiSMGreenblattRMBacchettiPNevirapine concentration in hair samples is a strong predictor of virologic suppression in a prospective cohort of HIV-infected patientsPLoS One201510e012910026053176
   PubMed Web of Science ®Google Scholar
• ViswanathanSJusticeACAlexanderGCAdherence and HIV RNA suppression in the current era of highly active antiretroviral therapyJ Acquir Immune Defic Syndr20156949349825886923
   PubMed Web of Science ®Google Scholar
• WilkinsELCohenCJTrottierBPatient-reported outcomes in the single-tablet regimen (STaR) trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/teno-fovir disoproxil fumarate in antiretroviral treatment-naive adults infected with HIV-1 through 48 weeks of treatmentAIDS Care20162840140826489045
   PubMed Web of Science ®Google Scholar
• BonoraSCalcagnoAViganoOEfficacy, tolerability and viro-logical consequences of long-term use of unboosted atazanavir plus 2 NRTIs in HIV-infected patientsCurr HIV Res20141233934625106410
   PubMed Web of Science ®Google Scholar
• DragovicGSalemovicDRaninJNikolicJKusicJJevtovicDClinical and immunologic outcomes of HAART-treated HIV-infected women in resource constrain settings: the Belgrade studyWomen Health201454354724555810
   PubMed Web of Science ®Google Scholar
• Hernandez ArroyoMJCabrera FigueroaSESepulveda CorreaRImpact of a pharmaceutical care program on clinical evolution and antiretroviral treatment adherence: a 5-year studyPatient Prefer Adherence2013772973923983457
   PubMed Web of Science ®Google Scholar
• JayaweeraDDejesusENguyenKLGrimmKButcherDSeekinsDWVirologic suppression, treatment adherence, and improved quality of life on a once-daily efavirenz-based regimen in treatment-Naive HIV-1-infected patients over 96 weeksHIV Clin Trials20091037538420133268
   PubMed Web of Science ®Google Scholar
• JulianFSMartinPEricksonSRValidation of the special projects of national significance adherence tool in HIV/AIDS patientsAnn Pharmacother2010441003100920442352
   PubMed Web of Science ®Google Scholar
• MartinMDel CachoECodinaCRelationship between adherence level, type of the antiretroviral regimen, and plasma HIV type 1 RNA viral load: a prospective cohort studyAIDS Res Hum Retroviruses2008241263126818834323
   PubMed Web of Science ®Google Scholar
• PodzamczerDRozasNDomingoPACTG-HIV symptoms changes in patients switched to RPV/FTC/TDF due to previous intolerance to CART. Interim analysis of the PRO-STR studyJ Int AIDS Soc2014174 Suppl 31981425397558
   PubMed Web of Science ®Google Scholar
• Torres-CornejoABenmarzouk-HidalgoOJGutierrez-ValenciaACellular HIV reservoir replenishment is not affected by blip or intermittent viremia episodes during darunavir/ritonavir monotherapyAIDS20142820120824361681
   PubMed Web of Science ®Google Scholar
• ChakrabortyHWeissmanSDuffusWAHIV community viral load trends in South CarolinaInt J STD AIDS20163131
   Google Scholar
• DeJesusERockstrohJKHenryKCo-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trialLancet20123792429243822748590
   PubMed Web of Science ®Google Scholar
• RiceTRosenauPUnruhLYBarnesAJSaltmanRBvan GinnekenEUnited States of America: health system reviewHealth Syst Transit2013151431
   PubMedGoogle Scholar
• SrivastavaKAroraAKatariaACappelleriJCSadoskyAPetersonAMImpact of reducing dosing frequency on adherence to oral therapies: a literature review and meta-analysisPatient Prefer Adherence2013741943423737662
   PubMed Web of Science ®Google Scholar
• CohenCJColsonAESheble-HallAGMcLaughlinKAMorseGDPilot study of a novel short-cycle antiretroviral treatment interruption strategy: 48-week results of the five-days-on, two-days-off (FOTO) studyHIV Clin Trials20078192317434845
   PubMed Web of Science ®Google Scholar
• Antiretroviral Therapy Cohort CollaborationSurvival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studiesLancet HIV20174e349e35628501495
   PubMed Web of Science ®Google Scholar
• TrancartSCharreauIMarchouBPresence of lamivudine or emtricitabine is associated with reduced emergence of nonnucleoside reverse transcriptase inhibitor mutations in an efavirenz-based intermittent antiretroviral treatment regimenAntimicrob Agents Chemother2012561655165722203586
   PubMed Web of Science ®Google Scholar
• BangsbergDRRaglandKMonkADeeksSGA single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV+ homeless and marginally housed peopleAIDS2010242835284021045636
   PubMed Web of Science ®Google Scholar
• ReisACPrista GuerraMLencastreLTreatment adherence, quality of life and clinical variables in HIV/AIDS infectionJ Int AIDS Soc200013Suppl 4119
   Google Scholar
• SaagMSBensonCAGandhiRTAntiretroviral drugs for treatment and prevention of HIV infection in adults: 2018 recommendations of the International Antiviral Society-USA PanelJAMA201832037939630043070
   PubMed Web of Science ®Google Scholar